A comparative study of teriflunomide and dimethyl fumarate within the Swedish MS Registry

BACKGROUND: Teriflunomide and dimethyl fumarate (DMF) are first-line disease-modifying treatments for multiple sclerosis with similar labels that are used in comparable populations. OBJECTIVES: The objective of this study was to compare the effectiveness and persistence of teriflunomide and DMF in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hillert, Jan, Tsai, Jon A, Nouhi, Mona, Glaser, Anna, Spelman, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795225/
https://www.ncbi.nlm.nih.gov/pubmed/34080926
http://dx.doi.org/10.1177/13524585211019649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795225/
https://www.ncbi.nlm.nih.gov/pubmed/34080926
http://dx.doi.org/10.1177/13524585211019649

Ejemplares similares